Nomenclature for human DPYD alleles

H L McLeod, E S R Collie-Duguid, P Vreken, M R Johnson, X Wei, A Sapone, R B Diasio, P Fernandez-Salguero, A B P van Kuilenberg, A H van Gennip, F J Gonzalez

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

To standardize DPYD allele nomenclature and to conform with international human gene nomenclature guidelines, an alternative to the current arbitrary system is described. Based on recommendations for human genome nomenclature, we propose that each distinct allele be designed by DPYD followed by an asterisk and an Arabic numeral. The number specifies the key mutation and, where appropriate, a letter following the number indicates an additional mutation on the mutant allele, Criteria for classification as a distinct allele are also presented. Pharmacogenetics 8:455-459. (C) 1998 Lippincott Williams & Wilkins.

Original languageEnglish
Pages (from-to)455-459
Number of pages5
JournalPharmacogenetics
Volume8
Publication statusPublished - 1998

Keywords

  • allele nomenclature
  • DPYD
  • dihydropyrimidine dehydrogenase
  • pyrimidine metabolism
  • DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY
  • 5-FLUOROURACIL TOXICITY
  • MONONUCLEAR-CELLS
  • CANCER-PATIENTS
  • MOLECULAR-BASIS
  • GENE
  • IDENTIFICATION
  • CHEMOTHERAPY
  • POPULATION
  • LIVER

Cite this

McLeod, H. L., Collie-Duguid, E. S. R., Vreken, P., Johnson, M. R., Wei, X., Sapone, A., ... Gonzalez, F. J. (1998). Nomenclature for human DPYD alleles. Pharmacogenetics, 8, 455-459.

Nomenclature for human DPYD alleles. / McLeod, H L ; Collie-Duguid, E S R ; Vreken, P ; Johnson, M R ; Wei, X ; Sapone, A ; Diasio, R B ; Fernandez-Salguero, P ; van Kuilenberg, A B P ; van Gennip, A H ; Gonzalez, F J .

In: Pharmacogenetics, Vol. 8, 1998, p. 455-459.

Research output: Contribution to journalArticle

McLeod, HL, Collie-Duguid, ESR, Vreken, P, Johnson, MR, Wei, X, Sapone, A, Diasio, RB, Fernandez-Salguero, P, van Kuilenberg, ABP, van Gennip, AH & Gonzalez, FJ 1998, 'Nomenclature for human DPYD alleles', Pharmacogenetics, vol. 8, pp. 455-459.
McLeod HL, Collie-Duguid ESR, Vreken P, Johnson MR, Wei X, Sapone A et al. Nomenclature for human DPYD alleles. Pharmacogenetics. 1998;8:455-459.
McLeod, H L ; Collie-Duguid, E S R ; Vreken, P ; Johnson, M R ; Wei, X ; Sapone, A ; Diasio, R B ; Fernandez-Salguero, P ; van Kuilenberg, A B P ; van Gennip, A H ; Gonzalez, F J . / Nomenclature for human DPYD alleles. In: Pharmacogenetics. 1998 ; Vol. 8. pp. 455-459.
@article{429b8a1dd1164d42bc0ce32deac6f5a3,
title = "Nomenclature for human DPYD alleles",
abstract = "To standardize DPYD allele nomenclature and to conform with international human gene nomenclature guidelines, an alternative to the current arbitrary system is described. Based on recommendations for human genome nomenclature, we propose that each distinct allele be designed by DPYD followed by an asterisk and an Arabic numeral. The number specifies the key mutation and, where appropriate, a letter following the number indicates an additional mutation on the mutant allele, Criteria for classification as a distinct allele are also presented. Pharmacogenetics 8:455-459. (C) 1998 Lippincott Williams & Wilkins.",
keywords = "allele nomenclature, DPYD, dihydropyrimidine dehydrogenase, pyrimidine metabolism, DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY, 5-FLUOROURACIL TOXICITY, MONONUCLEAR-CELLS, CANCER-PATIENTS, MOLECULAR-BASIS, GENE, IDENTIFICATION, CHEMOTHERAPY, POPULATION, LIVER",
author = "McLeod, {H L} and Collie-Duguid, {E S R} and P Vreken and Johnson, {M R} and X Wei and A Sapone and Diasio, {R B} and P Fernandez-Salguero and {van Kuilenberg}, {A B P} and {van Gennip}, {A H} and Gonzalez, {F J}",
year = "1998",
language = "English",
volume = "8",
pages = "455--459",
journal = "Pharmacogenetics",
issn = "0960-314X",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Nomenclature for human DPYD alleles

AU - McLeod, H L

AU - Collie-Duguid, E S R

AU - Vreken, P

AU - Johnson, M R

AU - Wei, X

AU - Sapone, A

AU - Diasio, R B

AU - Fernandez-Salguero, P

AU - van Kuilenberg, A B P

AU - van Gennip, A H

AU - Gonzalez, F J

PY - 1998

Y1 - 1998

N2 - To standardize DPYD allele nomenclature and to conform with international human gene nomenclature guidelines, an alternative to the current arbitrary system is described. Based on recommendations for human genome nomenclature, we propose that each distinct allele be designed by DPYD followed by an asterisk and an Arabic numeral. The number specifies the key mutation and, where appropriate, a letter following the number indicates an additional mutation on the mutant allele, Criteria for classification as a distinct allele are also presented. Pharmacogenetics 8:455-459. (C) 1998 Lippincott Williams & Wilkins.

AB - To standardize DPYD allele nomenclature and to conform with international human gene nomenclature guidelines, an alternative to the current arbitrary system is described. Based on recommendations for human genome nomenclature, we propose that each distinct allele be designed by DPYD followed by an asterisk and an Arabic numeral. The number specifies the key mutation and, where appropriate, a letter following the number indicates an additional mutation on the mutant allele, Criteria for classification as a distinct allele are also presented. Pharmacogenetics 8:455-459. (C) 1998 Lippincott Williams & Wilkins.

KW - allele nomenclature

KW - DPYD

KW - dihydropyrimidine dehydrogenase

KW - pyrimidine metabolism

KW - DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY

KW - 5-FLUOROURACIL TOXICITY

KW - MONONUCLEAR-CELLS

KW - CANCER-PATIENTS

KW - MOLECULAR-BASIS

KW - GENE

KW - IDENTIFICATION

KW - CHEMOTHERAPY

KW - POPULATION

KW - LIVER

M3 - Article

VL - 8

SP - 455

EP - 459

JO - Pharmacogenetics

JF - Pharmacogenetics

SN - 0960-314X

ER -